metaEvidence - overview


			deaths (OS)	progression or deaths (PFS)	RFS/DFS
mML - L1 - all population metastatic/adv melanoma (mML) mML - 1st line (L1) mML - L1 - all population
versus nivolumab alone
	relatlimab plus nivolumab vs. nivolumab alone	1	-	NaN [NaN; NaN] /10000 0/0 vs. 0/0	-